The Phase III DIAMOND trial met both its primary and secondary endpoints of reducing tics in both children and adult patients ...

TikToker Baylen Dupree, who shares her life with Tourette Syndrome on social media, announced her engagement to Colin Dooley ...

Results from a Phase III registrational study suggest that ecopipam has potential as a first-in-class dopamine-1 receptor ...

Baylen Out Loud star Baylen Dupree has given fans a close-up glimpse at her engagement ring from fiancé Colin Dooley. The TLC ...

Since Baylen Out Loud premiered on TLC in January 2025, Tourette syndrome advocate Baylen Dupree has gained even more social ...

Baylen Dupree was interviewed on the 'Not Skinny But Not Fat' podcast on Feb. 19 and revealed she doesn't get tics when she's ...

Ecopipam showed statistical significance in treating Tourette syndrome versus a placebo for both its primary efficacy ...

Wake Forest University School of Medicine and Atrium Health Wake Forest Baptist Medical Center have been recognized by the ...

Emalex Biosciences’ dopamine blocker led to fewer patients with Tourette syndrome relapsing in a phase 3 trial, setting the ...

In the Phase III trial, 41.9% of pediatric Tourette syndrome patients relapsed after ecopipam treatment, as compared with ...

Emalex Biosciences said its daily oral tablet helped reduce relapses for children and adults with Tourette syndrome in a ...

TLC’s breakout series, Baylen Out Loud, is getting a second season, per a recent press release from the network. The series ...